Maria Di Perna
Pagani, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study.
Journal: European journal of haematology
Published: July 14, 2025
An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.
Journal: Annals of hematology
Published: April 18, 2025
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design.
Journal: Annals of hematology
Published: March 25, 2025
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
Journal: European journal of haematology
Published: July 23, 2024
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.
Journal: Targeted oncology
Published: September 08, 2023
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience.
Journal: Frontiers in oncology
Published: August 23, 2022
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies-bendamustine and G-CSF support.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: August 28, 2018
Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma.
Journal: British journal of haematology
Published: July 25, 2017
Safety and comfort of domestic bortezomib injection in real-life experience.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 24, 2017
Last Updated: 09/26/2026